Coexpression cluster:C997
From FANTOM5_SSTAR
Full id: C997_testis_Neutrophils_Reticulocytes_embryonic_Basophils_CD14_tridermal
Phase1 CAGE Peaks
Hg19::chr11:64619747..64619758,+ | p@chr11:64619747..64619758 + |
Hg19::chr17:4269248..4269257,- | p@chr17:4269248..4269257 - |
Hg19::chr17:74732889..74732898,+ | p19@MFSD11 |
Hg19::chr19:7621690..7621698,+ | p@chr19:7621690..7621698 + |
Hg19::chr1:179335101..179335112,+ | p6@AXDND1 |
Hg19::chr22:40440578..40440589,- | p5@BC038752 |
Hg19::chr3:38181238..38181245,+ | p10@MYD88 |
Hg19::chr5:176433664..176433675,- | p10@UIMC1 |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
No results for this coexpression
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0008063 | Toll signaling pathway | 0.00581292669125172 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 0.00581292669125172 |
GO:0002238 | response to molecule of fungal origin | 0.00581292669125172 |
GO:0005121 | Toll binding | 0.00581292669125172 |
GO:0032760 | positive regulation of tumor necrosis factor production | 0.00581292669125172 |
GO:0002221 | pattern recognition receptor signaling pathway | 0.00581292669125172 |
GO:0002224 | toll-like receptor signaling pathway | 0.00581292669125172 |
GO:0032496 | response to lipopolysaccharide | 0.00581292669125172 |
GO:0032680 | regulation of tumor necrosis factor production | 0.00581292669125172 |
GO:0031663 | lipopolysaccharide-mediated signaling pathway | 0.00581292669125172 |
GO:0002218 | activation of innate immune response | 0.00581292669125172 |
GO:0002758 | innate immune response-activating signal transduction | 0.00581292669125172 |
GO:0045080 | positive regulation of chemokine biosynthetic process | 0.00606476986366401 |
GO:0005123 | death receptor binding | 0.00606476986366401 |
GO:0032606 | interferon type I production | 0.00606476986366401 |
GO:0048661 | positive regulation of smooth muscle cell proliferation | 0.00606476986366401 |
GO:0045351 | interferon type I biosynthetic process | 0.00606476986366401 |
GO:0045073 | regulation of chemokine biosynthetic process | 0.00606476986366401 |
GO:0032602 | chemokine production | 0.00606476986366401 |
GO:0002237 | response to molecule of bacterial origin | 0.00606476986366401 |
GO:0050755 | chemokine metabolic process | 0.00606476986366401 |
GO:0045089 | positive regulation of innate immune response | 0.00606476986366401 |
GO:0042033 | chemokine biosynthetic process | 0.00606476986366401 |
GO:0045088 | regulation of innate immune response | 0.00639309001654277 |
GO:0048660 | regulation of smooth muscle cell proliferation | 0.00669511170903356 |
GO:0046330 | positive regulation of JNK cascade | 0.00671557792129226 |
GO:0032640 | tumor necrosis factor production | 0.00671557792129226 |
GO:0048659 | smooth muscle cell proliferation | 0.00697366406672733 |
GO:0046328 | regulation of JNK cascade | 0.00883200757828019 |
GO:0009620 | response to fungus | 0.00883200757828019 |
GO:0033002 | muscle cell proliferation | 0.00899668680374902 |
GO:0051092 | activation of NF-kappaB transcription factor | 0.00971828956965259 |
GO:0001819 | positive regulation of cytokine production | 0.00971828956965259 |
GO:0051091 | positive regulation of transcription factor activity | 0.0123006698922749 |
GO:0002757 | immune response-activating signal transduction | 0.0127450863918242 |
GO:0002764 | immune response-regulating signal transduction | 0.0127779004540503 |
GO:0042108 | positive regulation of cytokine biosynthetic process | 0.0150364740853321 |
GO:0001817 | regulation of cytokine production | 0.0150364740853321 |
GO:0019221 | cytokine and chemokine mediated signaling pathway | 0.0153646976845699 |
GO:0016064 | immunoglobulin mediated immune response | 0.0171711618613322 |
GO:0051090 | regulation of transcription factor activity | 0.0171711618613322 |
GO:0019724 | B cell mediated immunity | 0.0171711618613322 |
GO:0045727 | positive regulation of translation | 0.0171711618613322 |
GO:0042035 | regulation of cytokine biosynthetic process | 0.018571264058464 |
GO:0031328 | positive regulation of cellular biosynthetic process | 0.018571264058464 |
GO:0007254 | JNK cascade | 0.0192787277651109 |
GO:0042089 | cytokine biosynthetic process | 0.0192787277651109 |
GO:0042107 | cytokine metabolic process | 0.0192787277651109 |
GO:0031098 | stress-activated protein kinase signaling pathway | 0.0192787277651109 |
GO:0009891 | positive regulation of biosynthetic process | 0.0192787277651109 |
GO:0002253 | activation of immune response | 0.0192787277651109 |
GO:0002449 | lymphocyte mediated immunity | 0.0192787277651109 |
GO:0002250 | adaptive immune response | 0.01959376415031 |
GO:0002460 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 0.01959376415031 |
GO:0002443 | leukocyte mediated immunity | 0.0197426010253207 |
GO:0050778 | positive regulation of immune response | 0.0206367145530951 |
GO:0051247 | positive regulation of protein metabolic process | 0.0206367145530951 |
GO:0002684 | positive regulation of immune system process | 0.0206367145530951 |
GO:0050776 | regulation of immune response | 0.0224387813527228 |
GO:0009615 | response to virus | 0.0224387813527228 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB cascade | 0.0224387813527228 |
GO:0002682 | regulation of immune system process | 0.0224387813527228 |
GO:0051240 | positive regulation of multicellular organismal process | 0.0230377501732489 |
GO:0009617 | response to bacterium | 0.0230377501732489 |
GO:0043122 | regulation of I-kappaB kinase/NF-kappaB cascade | 0.0231099484407606 |
GO:0002252 | immune effector process | 0.0231799092542062 |
GO:0001816 | cytokine production | 0.0233135133751135 |
GO:0045087 | innate immune response | 0.0233135133751135 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 0.0275936114911375 |
GO:0007249 | I-kappaB kinase/NF-kappaB cascade | 0.0275936114911375 |
GO:0000165 | MAPKKK cascade | 0.02934836211627 |
GO:0009967 | positive regulation of signal transduction | 0.0295169502447868 |
GO:0006417 | regulation of translation | 0.0349792540799756 |
GO:0031326 | regulation of cellular biosynthetic process | 0.0373030904630282 |
GO:0051707 | response to other organism | 0.0380925236663848 |
GO:0009889 | regulation of biosynthetic process | 0.0395857622340122 |
GO:0045893 | positive regulation of transcription, DNA-dependent | 0.0401448774887949 |
GO:0008284 | positive regulation of cell proliferation | 0.0413951240740178 |
GO:0051239 | regulation of multicellular organismal process | 0.0479245649695406 |
GO:0045941 | positive regulation of transcription | 0.0479245649695406 |
GO:0045935 | positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process | 0.0479245649695406 |
GO:0009607 | response to biotic stimulus | 0.0479245649695406 |
GO:0006954 | inflammatory response | 0.0479245649695406 |
GO:0016481 | negative regulation of transcription | 0.0479245649695406 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br>disease_data<br>
Ontology term | p-value | n |
---|---|---|
corpus callosum | 3.07e-16 | 1 |
central nervous system cell part cluster | 3.07e-16 | 1 |
axon tract | 3.07e-16 | 1 |
intercerebral commissure | 3.07e-16 | 1 |
dorsal telencephalic commissure | 3.07e-16 | 1 |
brain white matter | 3.07e-16 | 1 |
brain commissure | 3.07e-16 | 1 |
white matter | 3.07e-16 | 1 |
nervous system commissure | 3.07e-16 | 1 |
cerebral hemisphere white matter | 3.07e-16 | 1 |
multi cell component structure | 8.74e-09 | 2 |
neuron projection bundle | 8.74e-09 | 2 |
testis | 9.31e-09 | 8 |
Ontology term | p-value | n |
---|---|---|
lymphoma | 5.94e-07 | 10 |
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
MA0003.1 | 0.797136 |
MA0004.1 | 1.15451 |
MA0006.1 | 0.300178 |
MA0007.1 | 0.437331 |
MA0009.1 | 0.918715 |
MA0014.1 | 1.38556 |
MA0017.1 | 0.337901 |
MA0019.1 | 0.602411 |
MA0024.1 | 0.813542 |
MA0025.1 | 1.05265 |
MA0027.1 | 2.5321 |
MA0028.1 | 0.846854 |
MA0029.1 | 0.832916 |
MA0030.1 | 0.821423 |
MA0031.1 | 0.756713 |
MA0038.1 | 0.557409 |
MA0040.1 | 0.838784 |
MA0041.1 | 1.19384 |
MA0042.1 | 1.12605 |
MA0043.1 | 0.919032 |
MA0046.1 | 0.90778 |
MA0048.1 | 0.0955945 |
MA0050.1 | 0.443405 |
MA0051.1 | 0.553205 |
MA0052.1 | 0.842664 |
MA0055.1 | 0.283474 |
MA0056.1 | 0 |
MA0057.1 | 0.632427 |
MA0058.1 | 1.69448 |
MA0059.1 | 0.948176 |
MA0060.1 | 1.67203 |
MA0061.1 | 0.497495 |
MA0063.1 | 0 |
MA0066.1 | 1.3723 |
MA0067.1 | 1.23721 |
MA0068.1 | 0.823119 |
MA0069.1 | 0.903908 |
MA0070.1 | 0.892666 |
MA0071.1 | 0.518907 |
MA0072.1 | 0.888148 |
MA0073.1 | 1.05311 |
MA0074.1 | 0.552456 |
MA0076.1 | 0.985027 |
MA0077.1 | 0.880402 |
MA0078.1 | 0.652193 |
MA0081.1 | 0.361233 |
MA0083.1 | 0.926258 |
MA0084.1 | 1.42483 |
MA0087.1 | 0.885691 |
MA0088.1 | 0.441522 |
MA0089.1 | 0 |
MA0090.1 | 0.391903 |
MA0091.1 | 0.458301 |
MA0092.1 | 1.07975 |
MA0093.1 | 1.48478 |
MA0095.1 | 0 |
MA0098.1 | 0 |
MA0100.1 | 0.571227 |
MA0101.1 | 0.30624 |
MA0103.1 | 0.291333 |
MA0105.1 | 0.586268 |
MA0106.1 | 0.59853 |
MA0107.1 | 0.236528 |
MA0108.2 | 0.753643 |
MA0109.1 | 0 |
MA0111.1 | 0.405141 |
MA0113.1 | 0.614917 |
MA0114.1 | 0.231781 |
MA0115.1 | 1.1606 |
MA0116.1 | 0.239768 |
MA0117.1 | 0.956472 |
MA0119.1 | 0.345493 |
MA0122.1 | 0.982472 |
MA0124.1 | 1.11898 |
MA0125.1 | 1.0347 |
MA0130.1 | 0 |
MA0131.1 | 1.60834 |
MA0132.1 | 0 |
MA0133.1 | 0 |
MA0135.1 | 0.949204 |
MA0136.1 | 0.564434 |
MA0139.1 | 0.470675 |
MA0140.1 | 0.516266 |
MA0141.1 | 0.359385 |
MA0142.1 | 0.724856 |
MA0143.1 | 0.615094 |
MA0144.1 | 0.623945 |
MA0145.1 | 1.25866 |
MA0146.1 | 0.934908 |
MA0147.1 | 0.681318 |
MA0148.1 | 0.480298 |
MA0149.1 | 0.506665 |
MA0062.2 | 0.942487 |
MA0035.2 | 0.515566 |
MA0039.2 | 2.57832 |
MA0138.2 | 0.653421 |
MA0002.2 | 1.01797 |
MA0137.2 | 0.321796 |
MA0104.2 | 0.55506 |
MA0047.2 | 0.586412 |
MA0112.2 | 0.458158 |
MA0065.2 | 0.226158 |
MA0150.1 | 0.386144 |
MA0151.1 | 0 |
MA0152.1 | 0.52279 |
MA0153.1 | 1.01778 |
MA0154.1 | 0.974997 |
MA0155.1 | 0.43752 |
MA0156.1 | 0.323987 |
MA0157.1 | 0.697424 |
MA0158.1 | 0 |
MA0159.1 | 0.243637 |
MA0160.1 | 0.495355 |
MA0161.1 | 0 |
MA0162.1 | 2.16395 |
MA0163.1 | 0.288263 |
MA0164.1 | 0.627336 |
MA0080.2 | 0.303167 |
MA0018.2 | 0.599912 |
MA0099.2 | 0.523145 |
MA0079.2 | 2.50395 |
MA0102.2 | 1.46209 |
MA0258.1 | 0.209744 |
MA0259.1 | 0.699589 |
MA0442.1 | 0 |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)
TF | #promoters | Enrichment | p-value | q-value |
---|---|---|---|---|
CHD2#1106 | 4 | 5.17201141705843 | 0.00443788460794178 | 0.0210055848886849 |
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data
This analysis result is provided for C0 - C305 clusters.